SCHEMBL18308323

SCHEMBL18308323

COc1cc2c(cc1/C(C(C)=N)=C(\C)O)ncc1nnc(Cc3ccc(F)cc3)n12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 4/20 0.34
▸ MET P08581 4/20 0.33
▸ FYN P06241 2/20 0.33
▸ KIT P10721 2/20 0.33
▸ MAPT P10636 4/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ GPBAR1 Q8TDU6 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ALOX12 P18054 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ APLNR P35414 1/20 0.32
▸ PSEN1 P49768 2/20 0.31
▸ PSEN2 P49810 2/20 0.31
▸ APH1B Q8WW43 2/20 0.31
▸ NCSTN Q92542 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308324 0.92 MAPT (0.34) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL18308537 0.92 MAPT (0.36) IDH1METFYNKITMAPT
SCHEMBL18308344 0.91 KIT (0.36) IDH1METKITMAPTKDM4E
SCHEMBL18308539 0.90 MET (0.37) IDH1METFYNMAPTKDM4E
SCHEMBL18308394 0.89 APLNR (0.33) IDH1METAPLNR
SCHEMBL18308332 0.89 KIT (0.35) IDH1METKITALDH1A1NPSR1
SCHEMBL18308329 0.88 PLK1 (0.36) IDH1METMAPT
SCHEMBL18308342 0.86 PDE2A (0.36) METMAPTKDM4EALDH1A1LMNA
SCHEMBL18308331 0.86 RECQL (0.35) MAPTALDH1A1KMT2AMEN1LMNA
SCHEMBL18308325 0.86 KDM4E (0.35) METMAPTKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016199943-A1 HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-12-15 — — WO disclosed
Send feedback